Indicated for: thyroid disorders; radioiodine therapy
Substance: sodium iodide (131I) (thyroid hormone)
ATC: V10XA01 (Various | Other therapeutic radiopharmaceuticals | Iodine (131i) compounds)
Natrii iodidum (131I) is a radioactive compound used in the treatment and diagnosis of thyroid conditions such as hyperthyroidism and thyroid cancer. It emits radiation that destroys overactive or cancerous thyroid cells.
It is administered orally, in capsule or solution form, and is quickly absorbed by the thyroid gland. Treatment with Natrii iodidum (131I) is effective and minimally invasive, serving as an alternative to surgical interventions.
Side effects may include dry mouth, fatigue, or inflammation of the salivary glands. As a radioactive compound, its use requires special precautions to minimize radiation exposure.
Consult your doctor to discuss the benefits and risks of treatment with Natrii iodidum (131I). It is important to follow all instructions to ensure the safety and effectiveness of the treatment.